Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GREULICH, Heidi")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Medulloblastoma exome sequencing uncovers subtype―specific somatic mutationsPUGH, Trevor J; DILHAN WEERARATNE, Shyamal; GREULICH, Heidi et al.Nature (London). 2012, Vol 488, Num 7409, pp 106-110, issn 0028-0836, 5 p.Article

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptorALVAREZ, James V; GREULICH, Heidi; SELLERS, William R et al.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 3162-3168, issn 0008-5472, 7 p.Article

The landscape of somatic copy-number alteration across human cancersBEROUKHIM, Rameen; MERMEL, Craig H; MC HENRY, Kevin T et al.Nature (London). 2010, Vol 463, Num 7283, pp 899-905, issn 0028-0836, 7 p.Article

Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to PaclitaxelSAWAI, Ayana; CHANDARLAPATY, Sarat; GREULICH, Heidi et al.Cancer research (Baltimore). 2008, Vol 68, Num 2, pp 589-596, issn 0008-5472, 8 p.Article

Cetuximab Response of Lung Cancer―Derived EGF Receptor Mutants Is Associated with Asymmetric DimerizationJEONGHEE CHO; LIANG CHEN; GREULICH, Heidi et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 22, pp 6770-6779, issn 0008-5472, 10 p.Article

Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic FeaturesTAMAYO, Pablo; CHO, Yoon-Jae; POMEROY, Scott L et al.Journal of clinical oncology. 2011, Vol 29, Num 11, pp 1415-1423, issn 0732-183X, 9 p.Article

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyBARRETINA, Jordi; TAYLOR, Barry S; CHIANG, Derek Y et al.Nature genetics. 2010, Vol 42, Num 8, pp 715-721, issn 1061-4036, 7 p.Article

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance MutationSOS, Martin L; RODE, Haridas B; RUDDIGKEIT, Lars et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 3, pp 868-874, issn 0008-5472, 7 p.Article

Modeling Genomic Diversity and Tumor Dependency in Malignant MelanomaLIN, William M; BAKER, Alissa C; HODI, F. Stephen et al.Cancer research (Baltimore). 2008, Vol 68, Num 3, pp 664-673, issn 0008-5472, 10 p.Article

Valosin-containing protein phosphorylation at Ser784 in response to DNA damageLIVINGSTONE, Mark; HONG RUAN; MOCHAN, Tamara A et al.Cancer research (Baltimore). 2005, Vol 65, Num 17, pp 7533-7540, issn 0008-5472, 8 p.Article

Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical OutcomeCHO, Yoon-Jae; TSHERNIAK, Aviad; LAU, Ching C et al.Journal of clinical oncology. 2011, Vol 29, Num 11, pp 1424-1430, issn 0732-183X, 7 p.Article

Activating mutations in ALK provide a therapeutic target in neuroblastomaGEORGE, Rani E; SANDA, Takaomi; LIQUAN XUE et al.Nature (London). 2008, Vol 455, Num 7215, pp 975-978, issn 0028-0836, 4 p.Article

Somatic mutations affect key pathways in lung adenocarcinomaLI DING; GETZ, Gad; FULTON, Lucinda et al.Nature (London). 2008, Vol 455, Num 7216, pp 1069-1075, issn 0028-0836, 7 p.Article

High-throughput oncogene mutation profiling in human cancerTHOMAS, Roman K; BAKER, Alissa C; LEE, Jeffrey C et al.Nature genetics. 2007, Vol 39, Num 3, pp 347-351, issn 1061-4036, 5 p.Article

Characterizing the cancer genome in lung adenocarcinomaWEIR, Barbara A; WOO, Michele S; SHAH, Kinjal et al.Nature (London). 2007, Vol 450, Num 7171, pp 893-898, issn 0028-0836, 6 p.Article

Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progressionJINGRUI JIANG; GREULICH, Heidi; JÄNNE, Pasi A et al.Cancer research (Baltimore). 2005, Vol 65, Num 19, pp 8968-8974, issn 0008-5472, 7 p.Article

EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapyPAEZ, J. Guillermo; JÄNNE, Pasi A; NAOKI, Katsuhiko et al.Science (Washington, D.C.). 2004, Vol 304, Num 5676, pp 1497-1500, issn 0036-8075, 4 p.Article

  • Page / 1